SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-22-007695
Filing Date
2022-03-29
Accepted
2022-03-29 16:10:14
Documents
16
Period of Report
2022-03-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K advm-20220329.htm   iXBRL 8-K 35149
2 EX-99.1 exhibit991_032922pressrele.htm EX-99.1 21474
6 GRAPHIC logoa.jpg GRAPHIC 9327
7 GRAPHIC pr_bs.jpg GRAPHIC 93105
8 GRAPHIC pr_is.jpg GRAPHIC 57762
  Complete submission text file 0001628280-22-007695.txt   419115

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT advm-20220329.xsd EX-101.SCH 1911
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT advm-20220329_lab.xml EX-101.LAB 23970
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT advm-20220329_pre.xml EX-101.PRE 12644
10 EXTRACTED XBRL INSTANCE DOCUMENT advm-20220329_htm.xml XML 10551
Mailing Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 800 SAGINAW DRIVE REDWOOD CITY CA 94063 650-272-6269
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36579 | Film No.: 22780876
SIC: 2836 Biological Products, (No Diagnostic Substances)